Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials
PaperCitations, authors & open-access status
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 11 citations, 2017 year and bronze oa status.
11
Citations
2017
Year
bronze
OA Status